Study demonstrates Evonik omega-3 product’s high bioavailability


The study was done in collaboration with academics at the University of Wageningen. Evonik took no part in the study design and data collection

Study demonstrates Evonik omega-3 product’s high bioavailability

Evonik says the results of an in-human study published online in December 2020 in the journal Prostaglandins, Leukotrienes and Essential Fatty Acids prove its omega-3 product AvailOm boasts superior bioavailability versus a commercially available oil-based ethyl-ester formulation. Its technology of combining omega-3 fatty acids with the amino acid L-lysine enhances the rapid absorption of omega-3 in the body, increasing bioavailability by five times compared to traditional omega-3 soft gel products, the company claims.

“The results of this first in-human study provide compelling evidence that can improve the efficacy of omega-3 supplementation. Not only does the administration of EPA and DHA in the form of its lysine salt provide a novel and effective way to increase plasma levels of these important fatty acids, the stability and technical properties of the omega-3 lysine complex provide additional advantages that will allow the development of novel product formulations that may require lower doses. This study represents exciting opportunities for the optimization of omega-3 supplementation using the lysine complex”, said Renger Witkamp, Professor of Nutritional Biology at Wageningen University & Research.

The release and absorption characteristics of AvailOm offer supplement manufacturers opportunities for formulation technology and dosing. Dr Christopher Studte, Director New Health Ingredients at Evonik Health Care, said: “Evonik’s omega-3 lysine complex solves many challenges in the development of highly concentrated and yet convenient food supplements, addressing the needs of various consumer groups, such as pregnant women, mothers, and healthy agers.”

Dr Studte added: “We look forward to leveraging our AvailOm® platform, as well as our complementary formulation and scale-up services to help nutraceutical companies differentiate and accelerate speed to market.” Studte is one of Evonik’s leading experts in the field of omega-3 fatty acids.

Sign up for your free email newsletter

AvailOm is offered in three different grades: AvailOm50 High DHA Algae, AvailOm50 High DHA, AvailOm50 High EPA. All grades are produced from certified sustainable sources.